Latest Research News
Gilead bets $1.68B upfront on UCLA Bioengineering Alumni’s Ouro Medicines’ autoimmune program, with Galapagos expected to pitch in
Gilead Sciences is set to enter the T cell engager space in an unusual — perhaps even unprecedented — deal arrangement that involves the pharma budgeting about $1.68 billion upfront to buy Ouro Medicines and for Galapagos to do early work on the candidate. While the...
Implantable “Charging Station” Boosts Fight Against Cancer
Mar 17, 2026 UCLA Samueli Newsroom Immunotherapy has transformed cancer treatment by harnessing the body’s own immune system to fight disease. But many engineered immune cells lose strength quickly after they enter the body, especially inside tumors that actively...
Incoming UCLA Engineering Faculty Member Mohamad Abedi Awarded Michelson Prizes: Next Generation Grant for Cancer Immunotherapy Research
Mohamad Abedi, an incoming assistant professor of bioengineering at the UCLA Samueli School of Engineering, has been awarded a 2026 Michelson Prizes: Next Generation Grant to support his research developing next-generation immunotherapies for cancer. Abedi’s research...
Latest Department Announcements
ANEUVO Receives FDA Clearance for ExaStim®
Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) — ANEUVO, a medical technology company advancing non-invasive neuromodulation for people living with spinal cord injury, today announced U.S. Food and Drug Administration (FDA) clearance for its ExaStim® Stimulation...
UCLA Bioengineering Leaders Elected to AIMBE College of Fellows
The American Institute for Medical and Biological Engineering (AIMBE) has announced the election of Professor Jun Chen and Scott Gibson (Director, Global Operations Leadership at Amgen) to its prestigious College of Fellows, Class of 2026. Election to AIMBE represents...
Faculty Awards 2026
Dr. Anne Andrews, Ph.D.- ACS Analytical Chemistry Division Award in Electrochemistry
